Biotech Values

[DewDiligence]

>If 9902b shoots p<0.05, would you withhold approval because the MOA isn't precisely known? If the answer is no, then the MOA argument is moot.<

???

That’s bizarre reasoning, IMO.

If 9902b turns out statsig, the probably that the drug’s observed survival benefit is due to chance will be very much reduced relative to what it is today. This, in turn, would make the MoA investigation less consequential.